BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23855188)

  • 1. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
    Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
    Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y
    J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
    Suzuki-Inoue K
    J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets in lymph vessel development and integrity.
    Watson SP; Lowe K; Finney BA
    Adv Anat Embryol Cell Biol; 2014; 214():93-105. PubMed ID: 24276889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
    Suzuki-Inoue K; Osada M; Ozaki Y
    J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent development in platelet functions: roles beyond thrombosis].
    Ozaki Y; Inoue K; Inoue O
    Rinsho Byori; 2012 Jan; 60(1):52-8. PubMed ID: 22416457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
    Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
    J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CLEC-2 induced signalling in blood platelets].
    Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
    Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
    Hur J; Jang JH; Oh IY; Choi JI; Yun JY; Kim J; Choi YE; Ko SB; Kang JA; Kang J; Lee SE; Lee H; Park YB; Kim HS
    Mol Ther; 2014 Aug; 22(8):1518-1529. PubMed ID: 24736277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology.
    Suzuki-Inoue K; Tsukiji N
    Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets: covert regulators of lymphatic development.
    Bertozzi CC; Hess PR; Kahn ML
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2368-71. PubMed ID: 21071706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis.
    Carramolino L; Fuentes J; García-Andrés C; Azcoitia V; Riethmacher D; Torres M
    Circ Res; 2010 Apr; 106(7):1197-201. PubMed ID: 20203303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
    Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
    Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovenous hemostasis and the role of platelets in regulating lymphatic flow and lymphatic vessel maturation.
    Welsh JD; Kahn ML; Sweet DT
    Blood; 2016 Sep; 128(9):1169-73. PubMed ID: 27385789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.
    Ozaki Y; Tamura S; Suzuki-Inoue K
    Thromb J; 2016; 14(Suppl 1):27. PubMed ID: 27766053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
    Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
    J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.